LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Relative Growth Rate Standard Error of the Mean for Relative Growth Rate
SK-BR-3 SB590885
3.33
uM
LJP5
 1.1003 0.0097 1.1684 0.0226
SK-BR-3 PIK-93
3.33
uM
LJP5
 0.7481 0.0213 0.5839 0.0188
SK-BR-3 KIN001-043
3.33
uM
LJP6
 0.7960 0.0211 0.6565 0.0547
SK-BR-3 Alpelisib
3.33
uM
LJP5
 0.5820 0.0186 0.3029 0.0517
SK-BR-3 Luminespib
3.33
uM
LJP5
 0.4077 0.0208 0.0137 0.0616
SK-BR-3 A443654
3.33
uM
LJP6
 0.2449 0.0232 -0.2599 0.0948
SK-BR-3 OSI-027
3.33
uM
LJP6
 0.4297 0.0288 0.0499 0.0722
SK-BR-3 XMD11-85h
3.33
uM
LJP6
 0.8507 0.0214 0.7473 0.0483
SK-BR-3 HG-6-64-01
3.33
uM
LJP6
 0.5586 0.0179 0.2676 0.0182
SK-BR-3 WH-4-025
3.33
uM
LJP5
 0.8537 0.0673 0.7517 0.1130
SK-BR-3 WZ-4-145
3.33
uM
LJP6
 0.4579 0.0213 0.1005 0.0191
SK-BR-3 XMD16-144
3.33
uM
LJP5
 0.4004 0.0082 0.0018 0.0502
SK-BR-3 Brivanib
3.33
uM
LJP5
 0.9213 0.0362 0.8660 0.0610
SK-BR-3 Buparlisib
3.33
uM
LJP5
 0.2527 0.0143 -0.2468 0.0874
SK-BR-3 BX-912
3.33
uM
LJP5
 0.3739 0.0197 -0.0398 0.0298
SK-BR-3 Canertinib
3.33
uM
LJP6
 0.3343 0.0093 -0.1102 0.0728
SK-BR-3 Celastrol
3.33
uM
LJP6
 0.2691 0.0044 -0.2185 0.0737
SK-BR-3 CGP60474
3.33
uM
LJP5
 0.2478 0.0228 -0.2568 0.1056
SK-BR-3 CGP60474
3.33
uM
LJP6
 0.2040 0.0133 -0.3270 0.0838
SK-BR-3 CHIR-99021
3.33
uM
LJP6
 0.8378 0.0549 0.7206 0.1004
SK-BR-3 CP724714
3.33
uM
LJP5
 0.4395 0.0043 0.0661 0.0517
SK-BR-3 CP466722
3.33
uM
LJP5
 0.9219 0.0750 0.8829 0.1245
SK-BR-3 Crizotinib
3.33
uM
LJP5
 0.5913 0.0585 0.3258 0.0840
SK-BR-3 Momelotinib
3.33
uM
LJP5
 0.6942 0.0454 0.4958 0.0658
SK-BR-3 Dasatinib
3.33
uM
LJP5
 0.6814 0.0551 0.4713 0.0909